Table 3

Baseline assessment and changes in secondary outcomes from baseline to 10 weeks
Variable Intervention group Control group Between group change p
Total PA1 (METmin/week), mean±SD
 baseline 3282±3118 3770±3071 0.20†
 at 10 weeks 4992±5089 4497±4586
 change 1709±4430 727±4887 982 0.17‡
Moderate PA1 (METmin/week), mean±SD
 baseline 1568±1990 2061±2334 0.07†
 at 10 weeks 2518±3026 2346±3479
 change 950±2849 285±3842 665 0.19‡
Vigorous PA1 (METmin/week), mean±SD
 baseline 486±2036 311±853 0.74†
 at 10 weeks 979±2992 591±1559
 change 493±2445 279±1619 214 0.54‡
Walking PA1 (METmin/week), mean±SD
 baseline 1228±1441 1398±1564 0.44†
 at 10 weeks 1495±1617 1560±1687
 change 266±1988 163±2096 103 0.74‡
Pedometer2 determined steps/day, mean±SD
 baseline 6872±3585 7215±3368 0.61‡
 at 10 weeks 8128±4050 6788±3507
 change 1256±1933 −426±2754 1340 <0.001‡
SF36 PCS3, mean±SD
 baseline 40.4±7.7 41.2±5.9 0.51‡
 at 10 weeks 39.4±7.5 40.2±7.8
 change −0.9±8.5 −1.0±7.6 0.1 0.96‡
SF36 MCS3, mean±SD
 baseline 35.6±8.7 35.8±7.9 0.89‡
 at 10 weeks 34.8±7.9 35.3±7.4
 change −0.9±7.6 −0.5±6.8 0.4 0.77‡
BSI_PST4, mean±SD
 baseline 27.6±12.6 26.5±13.8 0.60‡
 at 10 weeks 25.3±12.8 24.0±14.5
 change −2.4±9.5 −2.5±7.5 0.1 0.92‡

PA, physical activity; PCS, physical component score; MCS, mental component score; BSI_PST, Brief Symptom Inventory Positive Symptom Total.

1Intervention group, n=127; Control group, n=60; 2 Intervention group, n=92; control group, n=40; 3Intervention group, n=112; control group, n=51; 4Intervention group, n=116; control group, n=55.

‡Independent Samples T-test, †Mann Whitney U test.

Verhaeghe et al.

Verhaeghe et al. BMC Public Health 2013 13:657   doi:10.1186/1471-2458-13-657

Open Data